2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Unknown
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Barrett Esophagus
15
Esophageal Neoplasms
10
Colorectal Neoplasms
10
Rectal Neoplasms
7
Adenocarcinoma Of Esophagus
7
Stomach Neoplasms
6
Nasopharyngeal Carcinoma
6
Colonic Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Gastroesophageal Reflux
4
Polyps
3
Pathologic Complete Response
3
Neoplasms
3
Lung Neoplasms
3
Colorectal Neoplasms, Hereditary Nonpolyposis
3
Carcinoma
3
Precancerous Conditions
2
Hyperplasia
2
Fistula
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Adenomatous Polyposis Coli
2
Adenocarcinoma
2
Urogenital Neoplasms
1
Upper Tract Urothelial Carcinoma
1
Thyroid Neoplasms
1
Stomach Ulcer
1
Stomach Diseases
1
Signs and Symptoms
1
Sarcoma
1
Interventions
Carboplatin
7
Trastuzumab
6
Docetaxel
5
pembrolizumab
4
Paclitaxel
4
Oxaliplatin
4
Fluorouracil
4
Cytarabine
4
Cyclophosphamide
4
Azacitidine
4
pertuzumab
3
Radiotherapy
3
Observation
3
Neoadjuvant Therapy
3
Epirubicin
3
Endoscopy
3
Cisplatin
3
Chemoradiotherapy
3
Capecitabine
3
venetoclax
2
toripalimab
2
sargramostim
2
olaparib
2
durvalumab
2
cc-486
2
Tretinoin
2
Surgical Procedures, Operative
2
Standard of Care
2
Pemetrexed
2
Monatide (IMS 3015)
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Endoscopy
×
Clear all
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled
NCT03125343
2023-11-07
WoW
Sahlgrenska University Hospital
Phase NA
Recruiting
400 enrolled
NCT03474341
2020-11-16
PRIDE
UMC Utrecht
Unknown
200 enrolled